
Allied Blenders and Distillers Limited (ABD) achieved its highest-ever monthly sales volumes in two consecutive months, with sales exceeding 3.5 million cases in September 2026 and crossing 3.6 million cases in October 2026. According to the company's latest filing under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, the combined volumes for the two months surpassed 7 million cases, marking the fourth monthly sales record in seven months this financial year. The company noted that this sustained momentum reflects consistent market demand and execution excellence, with growth broad-based across different regions, the defence market and international operations. Growth was supported by flagship brands such as the Officer's Choice franchise and ICONiQ White, with the inclusion of international markets as a contributor to this momentum suggesting that export channels are providing stability alongside domestic festive consumption.
Two brands crossed the one-million-cases-per-year threshold during this period, as reported by the company's latest filing. Officer's Choice Brandy joined ABD's millionaire brands club on the back of near double-digit market share in key southern states within the Mass Premium category. Sumo Whisky, the company's newer Mass Premium offering, also achieved millionaire brand status in October 2026, driven by consumer demand in southern markets. With these additions, ABD now counts six millionaire brands in its portfolio, reinforcing its product depth and market presence. The filing shows that the addition of these two new millionaire brands, Officer's Choice Brandy and Sumo Whisky, widens the base of high-volume products beyond the flagship Officer's Choice whisky franchise, reflecting the operational reach of the company's distribution network and brand portfolio.
ABD delivered exceptional financial results in Q2FY27, with consolidated income from operations reaching ₹1,152 crore, up 15.8% year-on-year, as reported by the company's latest filing. The company achieved highest-ever quarterly sales volumes of 10.0 million cases in Q2FY27, representing a significant increase from 8.5 million cases in Q4FY25. Net profit rose 9.7% year-on-year to ₹69 crore, demonstrating strong operational efficiency. Income from operations expanded by 17.1% quarter-on-quarter, reflecting the sustained momentum in sales volumes. The company's quarterly sales volumes scaled to 10.0 million cases in Q2FY27, up from 8.5 million cases in Q4FY25, showcasing consistent growth trajectory and operational excellence.
ABD's stock traded at ₹696.25 on Wednesday, up 0.24 per cent intraday, with a market capitalisation of approximately ₹19,475 crore, according to The Hindu BusinessLine. The scrip's 52-week high stands at ₹766.90, hit on October 15, 2026. ABD's stock has gained approximately 15.87 per cent year-to-date, against a negative 5.35 per cent return for the Nifty 500 over the same period. The latest performance builds on the volume growth recorded during the first half of FY27, with the continued momentum reflecting demand across brands and markets, with festive season sales providing an additional boost in September and October. The volume disclosures provide operational updates ahead of formal quarterly financial results, with revenue, margin, or profitability data to be disclosed through the formal results process.
ABD's super-premium subsidiary ABD Maestro Private Limited announced the expansion of its Rangeela Vodka range with two new flavours — Rangeela Jhatpat Jamun Vodka and Rangeela Kala Khatta Vodka, as reported by The Hindu BusinessLine. Inspired by Indian street food profiles, the flavoured vodkas are triple distilled and platinum chill filtered. They are currently available in Maharashtra in 750 ml and 180 ml formats, priced at ₹2,500 and ₹625 respectively, with Goa, Haryana and Uttar Pradesh launches to follow. The latest performance marks a significant milestone for ABD as it looks to strengthen its market presence through its existing brands, premiumisation and expansion across markets.